Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Antepsin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 20Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Elementis Pharma
    Germany
    		 Korea Pavise Pharmaceutical Co., Ltd. 20190625-211-J-370 sucralfate hydrate 2019-06-25 Elementis Pharma GmbH Germany Giulinistr. 2 67065 Ludwigshafen Germany
    29/11/2025 Zhejiang Haisen Pharmaceutical Co., Ltd.
    China
    		 Kukjeon Pharmaceutical Co., Ltd. 20190211-211-J-310(2) sucralfate hydrate 2019-04-22 Zhejiang Haisen Pharmaceutical Co., Ltd China Xiangtan Village, Liushi Street, Dongyang City, Zhejiang Province, China.